HB 483
  • Introduced
    Jan 12, 2026
  • Passed House
  • Passed Senate
  • Became Law
HB 483
Virginia House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Prescription Drug Affordability Board; established, drug cost affordability review, report.
Last Action See all actions
House • Feb 06, 2026: Subcommittee recommends reporting (6-Y 1-N)
Latest Bill Text See all bill texts
Introduced

Summary

Comments on HB 483

Tweets

Whip Lists

Sponsors
Votes
Jan 27, 2026, House
Subcommittee #1 Subcommittee recommends reporting with amendment(s) and rereferred to Appropriations (5-Y 4-N)
YES: 5
NO: 4
OTHER: 0
YES: 5

NO: 4

OTHER: 0
Sources
Jan 29, 2026, House
Labor and Commerce Reported from Labor and Commerce with amendment(s) and rereferred to Appropriations (14-Y 8-N)
YES: 14
NO: 8
OTHER: 0
YES: 14

NO: 8

OTHER: 0
Sources
Feb 06, 2026, House
Health & Human Resources Subcommittee recommends reporting (6-Y 1-N)
YES: 6
NO: 1
OTHER: 0
YES: 6

NO: 1

OTHER: 0
Sources
Actions
  • Feb 06, 2026 | House
    • Subcommittee recommends reporting (6-Y 1-N)
  • Jan 30, 2026 | House
    • Assigned HAPP sub: Health & Human Resources
  • Jan 29, 2026 | House
    • Reported from Labor and Commerce with amendment(s) and referred to Appropriations (14-Y 8-N)
  • Jan 27, 2026 | House
    • House subcommittee offered
    • Subcommittee recommends reporting with amendment(s) and referring to Appropriations (5-Y 4-N)
    • Fiscal Impact Statement from Department of Planning and Budget (HB483)
  • Jan 19, 2026 | House
    • Assigned HCL sub: Subcommittee #1
  • Jan 12, 2026 | House
    • Prefiled and ordered printed; Offered 01-14-2026 26104953D
    • Referred to Committee on Labor and Commerce
Bill Texts
Documents
Sources